About Samuel Waksal
Form D filings for Graviton BioScience from 2021 to 2024 list Samuel Waksal as chief executive officer and director.
Samuel Waksal first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Samuel Waksal in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Samuel Waksal works with at each company, as listed on that company's latest Form D.
Graviton BioScience Corp · Form D, Feb 14, 2024
BC
Bihua Chen
Director
JL
Jeremy Levin
Director
DM
David MacMillan
Director
JB
James Boylan
Director
SP
Stelios Papadopoulos
Director
RN
Ran Nussbaum
Director